Can we afford the future: effectiveness or cost-effectiveness as the criterion for introducing new therapies for breast cancer?
Tannock, I.F.Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/S1359-6349(08)70318-5
File:
PDF, 55 KB
english, 2008